ITOS News and Press, iTeos Therapeutics Inc. From 08/03/21

CAMBRIDGE, Mass. and GOSSELIES, Belgium, Aug. 03, 2021 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients, tod...

gguy44/iStock via Getty Images Piper Sandler Technical Market Strategist Craig. W. Johnson issued his July Alpha Alignment Report, which screens 900 stocks for a host of fundamental and technical factors. Along with the headline Alpha Alignment Index, the report also screens for an equal-weig...

CAMBRIDGE, Mass. and GOSSELIES, Belgium, July 08, 2021 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients, tod...

Kanizphoto/iStock via Getty Images iTeos Therapeutics ([[ITOS]] -2.9%) is trading lower after posting a record one-day gain yesterday in reaction to a collaboration with GlaxoSmithKline to jointly develop and commercialize anti-TIGIT antibody EOS-448. In addition to $625M as an upfront p...

peshkov/iStock via Getty Images Bitcoin (BTC-USD) received a boost on Monday thanks to comments from a couple of heavy hitters. Both Elon Musk and Paul Tudor Jones made remarks that goosed the cryptocurrency. Investors got some macro insight from a couple of top minds in the financial industr...

Shares of iTeos Therapeutics (NASDAQ: ITOS) surged 37% on Monday after it reached an agreement with GlaxoSmithKline (NYSE: GSK) to co-develop an experimental cancer treatment known as EOS-448. EOS-448 is a monoclonal antibody treatment for patients with cancer. It's curr...

Gainers: Enochian Biosciences ENOB +127%, RAPT Therapeutics RAPT +101%, iTeos Therapeutics ITOS +37%, Novan NOVN +30%, Anavex Life Sciences AVXL +23%.Losers: Avenue Therapeutics ATXI -39%, Inhibikase Therapeutics (IKT) -21%, ...

Compugen (CGEN) jumped 5.3% on some takeover speculation following GlaxoSmithKline's (GSK) agreement with iTeos Therapeutics (ITOS) to jointly develop and commercialize EOS-448 an anti-TIGIT monoclonal antibody currently undergoing Phase 1 studies as a potential cancer therapy....

Enochian Biosciences (ENOB) +143% on FDA acceptance of pre-IND request for potential HIV cure.MediaCo Holding (MDIA) +63%.iTeos Therapeutics (ITOS) +52%.Entasis Therapeutics Holdings (ETTX) +25%.Orphazyme A/S (ORPH) +23%.Luokung Technology (LKCO) +22%.Mereo BioPharma Group plc (MREO) +17...

JuSun/iStock via Getty Images iTeos Therapeutics (ITOS) has surged ~60.2% in the pre-market after announcing an agreement with GlaxoSmithKline (GSK) to jointly develop and commercialize EOS-448 an anti-TIGIT monoclonal antibody currently undergoing Phase 1 studies as a potential can...